Predicting virus Fitness: Towards a structure-based computational model

被引:2
|
作者
Thakur, Shivani [1 ]
Kepp, Kasper Planeta [2 ]
Mehra, Rukmankesh [1 ,3 ]
机构
[1] Indian Inst Technol Bhilai, Dept Chem, Durg 491001, Chhattisgarh, India
[2] Tech Univ Denmark, DTU Chem, Bldg 206, DK-2800 Lyngby, Denmark
[3] Indian Inst Technol Bhilai, Dept Biosci & Biomed Engn, Durg 491001, Chhattisgarh, India
关键词
SARS-CoV-2; Spike protein; Antibody; ACE2; Mutations; Computation; Fitness; RECEPTOR-BINDING DOMAIN; PROTEIN-STRUCTURE; TEMPERATURE; MUTATIONS; RESOLUTION; STABILITY; EVOLUTION; COVID-19; AFFINITY;
D O I
10.1016/j.jsb.2023.108042
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Predicting the impact of new emerging virus mutations is of major interest in surveillance and for understanding the evolutionary forces of the pathogens. The SARS-CoV-2 surface spike-protein (S-protein) binds to human ACE2 receptors as a critical step in host cell infection. At the same time, S-protein binding to human antibodies neutralizes the virus and prevents interaction with ACE2. Here we combine these two binding properties in a simple virus fitness model, using structure-based computation of all possible mutation effects averaged over 10 ACE2 complexes and 10 antibody complexes of the S-protein (similar to 380,000 computed mutations), and validated the approach against diverse experimental binding/escape data of ACE2 and antibodies. The ACE2-antibody selectivity change caused by mutation (i.e., the differential change in binding to ACE2 vs. immunity-inducing antibodies) is proposed to be a key metric of fitness model, enabling systematic error cancelation when evaluated. In this model, new mutations become fixated if they increase the selective binding to ACE2 relative to circulating antibodies, assuming that both are present in the host in a competitive binding situation. We use this model to categorize viral mutations that may best reach ACE2 before being captured by antibodies. Our model may aid the understanding of variant-specific vaccines and molecular mechanisms of viral evolution in the context of a human host.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Computational structure-based drug design: Predicting target flexibility
    Iglesias, Jelisa
    Saen-oon, Suwipa
    Soliva, Robert
    Guallar, Victor
    WILEY INTERDISCIPLINARY REVIEWS-COMPUTATIONAL MOLECULAR SCIENCE, 2018, 8 (05)
  • [2] A Structure-Based Model for Predicting Serum Albumin Binding
    Lexa, Katrina W.
    Dolghih, Elena
    Jacobson, Matthew P.
    PLOS ONE, 2014, 9 (04):
  • [3] Structure-based model for predicting serum albumin binding
    Lexa, Katrina W.
    Jacobson, Matthew P.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [4] Virus structure and structure-based antivirals
    Plavec, Zlatka
    Pohner, Ina
    Poso, Antti
    Butcher, Sarah J.
    CURRENT OPINION IN VIROLOGY, 2021, 51 : 16 - 24
  • [5] The Computational Complexity of Structure-Based Causality
    Aleksandrowicz, Gadi
    Chockler, Hana
    Halpern, Joseph Y.
    Ivrii, Alexander
    JOURNAL OF ARTIFICIAL INTELLIGENCE RESEARCH, 2017, 58 : 431 - 451
  • [6] The Computational Complexity of Structure-Based Causality
    Aleksandrowicz, Gadi
    Chockler, Hana
    Halpern, Joseph Y.
    Ivrii, Alexander
    PROCEEDINGS OF THE TWENTY-EIGHTH AAAI CONFERENCE ON ARTIFICIAL INTELLIGENCE, 2014, : 974 - 980
  • [7] Computational approaches to structure-based ligand design
    Joseph-McCarthy, D
    PHARMACOLOGY & THERAPEUTICS, 1999, 84 (02) : 179 - 191
  • [8] Computational tools for structure-based ligand design
    Bohm, HJ
    PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 1996, 66 (03): : 197 - 210
  • [9] Advances in computational structure-based antibody design
    Hummer, Alissa M.
    Abanades, Brennan
    Deane, Charlotte M.
    CURRENT OPINION IN STRUCTURAL BIOLOGY, 2022, 74
  • [10] Structure-based drug design: Computational advances
    Marrone, TJ
    Briggs, JM
    McCammon, JA
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1997, 37 : 71 - 90